DISODIUM 10B-FLUORO-3,4,4A,5,6,10A,10B,11,12,12A-DECAHYDRO-2,11-DIHYDROXY-3,10A,12A-TRIMETHYL-2-((PHOSPHONOOXY)METHYL)-1,8(2H,4BH)-CHRYSENEDIONE, (2S,3S,4AS,4BS,10AS,10BR,11S,12AS)-
UNII EG8D264VCY
Substance Identification & Data
This profile provides standardized clinical and technical data for Disodium 10b-fluoro-3,4,4a,5,6,10a,10b,11,12,12a-decahydro-2,11-dihydroxy-3,10a,12a-trimethyl-2-((phosphonooxy)methyl)-1,8(2h,4bh)-chrysenedione, (2s,3s,4as,4bs,10as,10br,11s,12as)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) EG8D264VCY.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1201919-21-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C22H28FO8P.2Na JQMLWKMUOSKQIT-JUDNMTCPSA-L Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Disodium 10b-fluoro-3,4,4a,5,6,10a,10b,11,12,12a-decahydro-2,11-dihydroxy-3,10a,12a-trimethyl-2-((phosphonooxy)methyl)-1,8(2h,4bh)-chrysenedione, (2s,3s,4as,4bs,10as,10br,11s,12as)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.